Skip to main content
SpringerLink
Log in

Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator

  • Original Paper
  • Published:
Journal of Molecular Modeling Aims and scope Submit manuscript

Abstract

Galanin receptor type 2 (GALR2) is a class A G-protein-coupled receptor (GPCR), and it has been reported that orthosteric ligands and positive allosteric modulators (PAMs) of GALR2 could potentially be used to treat epilepsy. So far, the X-ray structure of this receptor has not been resolved, and knowledge of the 3D structure of GALR2 may prove informative in attempts to design novel ligands and to explore the mechanism for the allosteric modulation of this receptor. In this study, homology modeling was used to obtain several GALR2 models using known templates. ProSA-web Z-scores and Ramachandran plots as well as pre-screening against a test dataset of known compounds were all utilized to select the best model of GALR2. Molecular dockings of galanin (a peptide) and a nonpeptide ligand were carried out to choose the (GALR2 model)–galanin complex that showed the closest agreement with the corresponding experimental data. Finally, a 50-ns MD simulation was performed to study the interactions between the GALR2 model and the synthetic and endogenous ligands. The results from docking and MD simulation showed that, besides the reported residues, Tyr1604.60, Ile1053.32, Ala2747.35, and Tyr163ECL2 also appear to play important roles in the binding of galanin. The potential allosteric binding pockets in the GALR2 model were then investigated via MD simulation. The results indicated that the mechanism for the allosteric modulation caused by PAMs is the binding of the PAM at pocket III, which is formed by galanin, ECL2, TM2, TM3, and ECL1; this results in the disruption of the Na+-binding site and/or the Na+ ion pathway, leading to GALR2 agonism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1a–b
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8a–b

Similar content being viewed by others

References

  1. George SR, O’Dowd BF, Lee SP (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 1(10):808–820

    Article  CAS  Google Scholar 

  2. Rask-Andersen M, Almen MS, Schioth HB (2011) Trends in the exploitation of novel drug targets. Nat Rev Drug Discov 10(8):579–590

    Article  CAS  Google Scholar 

  3. Overington JP, Al-Lazikani B, Hopkins AL (2006) Opinion: How many drug targets are there? Nat Rev Drug Discov 5(12):993–996

  4. Mitsukawa K, Lu X, Bartfai T (2008) Galanin, galanin receptors and drug targets. Cell Mol Life Sci 65(12):1796–1805

    Article  CAS  Google Scholar 

  5. Branchek TA, Smith KE, Gerald C, Walker MW (2000) Galanin receptor subtypes. Trends Pharmacol Sci 21(3):109–117

    Article  CAS  Google Scholar 

  6. Wang S, Hashemi T, Fried S, Clemmons AL, Hawes BE (1998) Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry 37(19):6711–6717

    Article  CAS  Google Scholar 

  7. Bartfai T, Lu X, Badie-Mahdavi H, Barr AM, Mazarati A, Hua XY, Yaksh T, Haberhauer G, Ceide SC, Trembleau L, Somogyi L, Krock L, Rebek J Jr (2004) Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci USA 101(28):10470–10475

  8. McGowan HW, Schuijers JA, Grills BL, McDonald SJ, McDonald AC (2014) Galnon, a galanin receptor agonist, improves intrinsic cortical bone tissue properties but exacerbates bone loss in an ovariectomised rat model. J Musculoskelet Neuronal Interact 14(2):162–172

    CAS  Google Scholar 

  9. Zhao X, Yun K, Seese RR, Wang Z (2013) Galnon facilitates extinction of morphine-conditioned place preference but also potentiates the consolidation process. PLoS One 8(10), e76395

    Article  CAS  Google Scholar 

  10. Wu WP, Hao JX, Lundstrom L, Wiesenfeld-Hallin Z, Langel U, Bartfai T, Xu XJ (2003) Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury. Eur J Pharmacol 482(1–3):133–137

    Article  CAS  Google Scholar 

  11. Bartfai T, Wang MW (2013) Positive allosteric modulators to peptide GPCRs: a promising class of drugs. Acta Pharmacol Sin 34(7):880–885

    Article  CAS  Google Scholar 

  12. Conn PJ, Lindsley CW, Meiler J, Niswender CM (2014) Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders. Nat Rev Drug Discov 13(9):692–708

    Article  CAS  Google Scholar 

  13. Nickols HH, Conn PJ (2014) Development of allosteric modulators of GPCRs for treatment of CNS disorders. Neurobiol Dis 61:55–71

    Article  Google Scholar 

  14. Lu XY, Roberts E, Xia FC, Sanchez-Alavez M, Liu TY, Baldwin R, Wu S, Chang J, Wasterlain CG, Bartfai T (2010) GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proc Natl Acad Sci USA 107(34):15229–15234

  15. Hoyer D (2010) Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealed. Proc Natl Acad Sci USA 107(34):14943–14944

  16. Conn PJ, Christopoulos A, Lindsley CW (2009) Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 8(1):41–54

    Article  CAS  Google Scholar 

  17. Feng ZW, Hu GX, Ma SF, Xie XQ (2015) Computational advances for the development of allosteric modulators and bitopic ligands in G protein-coupled receptors. AAPS J 17(5):1080–1095

  18. Feng ZW, Ma SF, Hu GX, Xie XQ (2015) Allosteric binding site and activation mechanism of class C G-protein coupled receptors: metabotropic glutamate receptor family. AAPS J 17(3):737–753

  19. Knoflach F, Mutel V, Jolidon S, Kew JN, Malherbe P, Vieira E, Wichmann J, Kemp JA (2001) Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. Proc Natl Acad Sci USA 98(23):13402–13407

  20. Voigtlander U, Johren K, Mohr M, Raasch A, Trankle C, Buller S, Ellis J, Holtje HD, Mohr K (2003) Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors. Mol Pharmacol 64(1):21–31

    Article  Google Scholar 

  21. Gerlach LO, Skerlj RT, Bridger GJ, Schwartz TW (2001) Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. J Biol Chem 276(17):14153–14160

    CAS  Google Scholar 

  22. Dror RO, Green HF, Valant C, Borhani DW, Valcourt JR, Pan AC, Arlow DH, Canals M, Lane JR, Rahmani R, Baell JB, Sexton PM, Christopoulos A, Shaw DE (2013) Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs. Nature 503(7475):295–299

    CAS  Google Scholar 

  23. Shang Y, LeRouzic V, Schneider S, Bisignano P, Pasternak GW, Filizola M (2014) Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions. Biochemistry 53(31):5140–5149

    Article  CAS  Google Scholar 

  24. Livingston KE, Traynor JR (2014) Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor. Proc Natl Acad Sci USA 111(51):18369–18374

  25. Rodriguez D, Ranganathan A, Carlsson J (2015) Discovery of GPCR ligands by molecular docking screening: novel opportunities provided by crystal structures. Curr Top Med Chem 15(24):2484–2503

    Article  CAS  Google Scholar 

  26. Costanzi S, Wang K (2014) The GPCR crystallography boom: providing an invaluable source of structural information and expanding the scope of homology modeling. Adv Exp Med Biol 796:3–13

    Article  CAS  Google Scholar 

  27. Lundstrom L, Sollenberg UE, Bartfai T, Langel U (2007) Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions. J Neurochem 103(5):1774–1784

    Article  Google Scholar 

  28. Wennerberg AB, Cooke RM, Carlquist M, Rigler R, Campbell ID (1990) A 1H NMR study of the solution conformation of the neuropeptide galanin. Biochem Biophys Res Commun 166(3):1102–1109

  29. Morris MB, Ralston GB, Biden TJ, Browne CL, King GF, Iismaa TP (1995) Structural and biochemical studies of human galanin: NMR evidence for nascent helical structures in aqueous solution. Biochemistry 34(14):4538–4545

    Article  CAS  Google Scholar 

  30. Parthiban M, Shanmughavel P (2007) Three dimensional modeling of N-terminal region of galanin and its interaction with the galanin receptor. Bioinformation 2(3):119–125

    Article  Google Scholar 

  31. Jurkowski W, Yazdi S, Elofsson A (2013) Ligand binding properties of human galanin receptors. Mol Membr Biol 30(2):206–216

    Article  Google Scholar 

  32. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289(5480):739–745

    Article  CAS  Google Scholar 

  33. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S (2012) Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 485(7398):321–326

    Article  CAS  Google Scholar 

  34. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318(5854):1258–1265

    Article  CAS  Google Scholar 

  35. Fenalti G, Giguere PM, Katritch V, Huang XP, Thompson AA, Cherezov V, Roth BL, Stevens RC (2014) Molecular control of delta-opioid receptor signalling. Nature 506(7487):191–196

    Article  CAS  Google Scholar 

  36. Warne T, Moukhametzianov R, Baker JG, Nehme R, Edwards PC, Leslie AG, Schertler GF, Tate CG (2011) The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor. Nature 469(7329):241–244

    Article  CAS  Google Scholar 

  37. Wu H, Wang C, Gregory KJ, Han GW, Cho HP, Xia Y, Niswender CM, Katritch V, Meiler J, Cherezov V, Conn PJ, Stevens RC (2014) Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator. Science 344(6179):58–64

    Article  CAS  Google Scholar 

  38. Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC (2012) Structure of the human kappa-opioid receptor in complex with JDTic. Nature 485(7398):327–332

    Article  CAS  Google Scholar 

  39. Wang C, Wu H, Katritch V, Han GW, Huang XP, Liu W, Siu FY, Roth BL, Cherezov V, Stevens RC (2013) Structure of the human smoothened receptor bound to an antitumour agent. Nature 497(7449):338–343

    Article  CAS  Google Scholar 

  40. Thompson AA, Liu W, Chun E, Katritch V, Wu H, Vardy E, Huang XP, Trapella C, Guerrini R, Calo G, Roth BL, Cherezov V, Stevens RC (2012) Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 485(7398):395–399

    Article  CAS  Google Scholar 

  41. Lebon G, Warne T, Edwards PC, Bennett K, Langmead CJ, Leslie AG, Tate CG (2011) Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature 474(7352):521–525

    Article  CAS  Google Scholar 

  42. Zhang J, Zhang K, Gao ZG, Paoletta S, Zhang D, Han GW, Li T, Ma L, Zhang W, Muller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q (2014) Agonist-bound structure of the human P2Y12 receptor. Nature 509(7498):119–122

    Article  CAS  Google Scholar 

  43. Isberg V, de Graaf C, Bortolato A, Cherezov V, Katritch V, Marshal FH, Mordalski S, Pin JP, Stevens RC, Vriend G, Gloriam DE (2015) Generic GPCR residue numbers—aligning topology maps while minding the gaps. Trends Pharmacol Sci 36(1):22–31

  44. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29:291–325

    Article  CAS  Google Scholar 

  45. Barany-Wallje E, Andersson A, Graslund A, Maler L (2004) NMR solution structure and position of transportan in neutral phospholipid bicelles. FEBS Lett 567(2–3):265–269

    Article  CAS  Google Scholar 

  46. Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35(Web Server issue):W407–W410

    Article  Google Scholar 

  47. Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26(2):283–291

    Article  CAS  Google Scholar 

  48. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605–1612

  49. Jain AN (1996) Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comput Aided Mol Des 10(5):427–440

    Article  CAS  Google Scholar 

  50. Pierce BG, Wiehe K, Hwang H, Kim BH, Vreven T, Weng ZP (2014) ZDOCK server: interactive docking prediction of protein–protein complexes and symmetric multimers. Bioinformatics 30(12):1771–1773

  51. Pedretti A, Villa L, Vistoli G (2002) VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model 21(1):47–49

    Article  CAS  Google Scholar 

  52. Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup of Poisson–Boltzmann electrostatics calculations. Nucleic Acids Res 32(Web Server issue):W665–W667

  53. Hsin J, Arkhipov A, Yin Y, Stone JE, Schulten K (2008) Using VMD: an introductory tutorial. Curr Protoc Bioinformatics 5:5.7

  54. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79(2):926–935

    Article  CAS  Google Scholar 

  55. Kalé L, Skeel R, Bhandarkar M, Brunner R, Gursoy A, Krawetz N, Phillips J, Shinozaki A, Varadarajan K, Schulten K (1999) NAMD2: greater scalability for parallel molecular dynamics. J Comput Phys 151(1):283–312

    Article  Google Scholar 

  56. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M (1983) CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4(2):187–217

    Article  CAS  Google Scholar 

  57. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiórkiewicz-Kuczera J, Yin D, Karplus M (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102(18):3586–3616

    Article  CAS  Google Scholar 

  58. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103(19):8577–8593

    Article  CAS  Google Scholar 

  59. Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22(12):2577–2637

    Article  CAS  Google Scholar 

  60. Khoddami M, Nadri H, Moradi A, Sakhteman A (2015) Homology modeling, molecular dynamic simulation, and docking based binding site analysis of human dopamine (D4) receptor. J Mol Model 21(2):36

  61. Cai Z, Ouyang Q, Zeng D, Nguyen KN, Modi J, Wang L, White AG, Rogers BE, Xie XQ, Anderson CJ (2014) (64)Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for pet imaging: in silico through in vivo studies. J Med Chem 57(14):6019–6029

    Article  CAS  Google Scholar 

  62. Floren A, Land T, Langel U (2000) Galanin receptor subtypes and ligand binding. Neuropeptides 34(6):331–337

    Article  CAS  Google Scholar 

  63. Bisignano P, Burford NT, Shang Y, Marlow B, Livingston KE, Fenton AM, Rockwell K, Budenholzer L, Traynor JR, Gerritz SW, Alt A, Filizola M (2015) Ligand-based discovery of a new scaffold for allosteric modulation of the mu-opioid receptor. J Chem Inf Model 55(9):1836–1843

    Article  CAS  Google Scholar 

  64. Burford NT, Livingston KE, Canals M, Ryan MR, Budenholzer LM, Han Y, Shang Y, Herbst JJ, O’Connell J, Banks M, Zhang L, Filizola M, Bassoni DL, Wehrman TS, Christopoulos A, Traynor JR, Gerritz SW, Alt A (2015) Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the delta-opioid receptor. J Med Chem 58(10):4220–4229

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful for the financial support from the NSFC (21202201 and 81202406) and the Third Military Medical University (2014XKJS01).

Author information

Authors and Affiliations

  1. College of Pharmacy, Third Military Medical University, No. 30 Gaotanyan Street, Chongqing, 400038, China

    Wen-Qi Hui, Qi Cheng, Tian-Yu Liu & Qin Ouyang

Authors
  1. Wen-Qi Hui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qi Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tian-Yu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qin Ouyang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Tian-Yu Liu or Qin Ouyang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 12696 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hui, WQ., Cheng, Q., Liu, TY. et al. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator. J Mol Model 22, 90 (2016). https://doi.org/10.1007/s00894-016-2944-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00894-016-2944-x

Keywords

Search

Navigation